Investigating how hearing and vision impairments affect the risk of Alzheimer's disease
Project 3: Prevention and Treatment of Hearing and Vision Impairments for Reducing AD/ADRD risk
This study is looking at how problems with hearing and vision might affect the chances of getting Alzheimer's disease, and it wants to find out if fixing these issues can help lower that risk, so it's for anyone interested in preventing Alzheimer's, especially those with sensory impairments.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston University Medical Campus NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10934716 on NIH RePORTER |
What this research studies
This research focuses on understanding the relationship between sensory impairments, such as hearing and vision loss, and the risk of developing Alzheimer's disease and related dementias. By utilizing large and diverse longitudinal studies, the project aims to identify whether treating these sensory impairments can effectively reduce the risk of Alzheimer's. The study will employ advanced methodologies to address potential biases and will consider various factors such as sex, race, and socioeconomic status that may influence outcomes. Ultimately, the goal is to provide insights that could lead to effective prevention strategies for Alzheimer's disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults experiencing hearing or vision impairments.
Not a fit: Patients without any sensory impairments or those who are not at risk for Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing Alzheimer's disease by addressing sensory impairments in older adults.
How similar studies have performed: Previous research has suggested that addressing sensory impairments may have beneficial effects on cognitive health, indicating potential for success in this approach.
Where this research is happening
Boston, United States
- Boston University Medical Campus — Boston, United States (Active)
Researchers
- Principal investigator: Brenowitz, Willa Domino — Boston University Medical Campus
- Study coordinator: Brenowitz, Willa Domino
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.